# Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer

> **NCT00973310** · PHASE2 · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Carcinoma, Non-Small Cell Lung

## Interventions

- **OTHER:** Radiation Therapy and EGFR-TKI target therapy

## Key facts

- **NCT ID:** NCT00973310
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973310, "Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00973310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*